安徽医科大学学报
安徽醫科大學學報
안휘의과대학학보
ACTA UNIVERSITY MEDICINALIS ANHUI
2015年
4期
452-457,458
,共7页
童斯浩%汪毅%龚理%钱振珏%柯章敏%鲍扬漪
童斯浩%汪毅%龔理%錢振玨%柯章敏%鮑颺漪
동사호%왕의%공리%전진각%가장민%포양의
乳腺癌%硫利达嗪%周期%凋亡%Caspase-3%Bcl-2%Bax
乳腺癌%硫利達嗪%週期%凋亡%Caspase-3%Bcl-2%Bax
유선암%류리체진%주기%조망%Caspase-3%Bcl-2%Bax
breast cancer%thioridazine%cell cycle%apoptosis%Caspase-3%Bcl-2%Bax
目的观察硫利达嗪对人乳腺癌细胞MDA-MB-231和MCF-7的凋亡作用,并探讨其机制。方法采用MTT法测定硫利达嗪对细胞的抑制作用,计算半数抑制浓度( IC50);流式细胞术检测硫利达嗪对细胞周期分布和凋亡的影响;比色法测定药物对细胞Caspase-3活性的影响;West-ern blot法检测凋亡调节蛋白Bcl-2、Bax表达的变化。结果<br> 硫利达嗪作用24 h后, MDA-MB-231、MCF-7细胞增殖明显呈剂量依赖性抑制,其IC50为18、22μmol/L。流式细胞术结果显示,随着加入硫利达嗪浓度的提高, MDA-MB-231、MCF-7细胞均发生不同程度的G0/G1期阻滞、细胞凋亡程度增加及伴随胞内Caspase-3活性增加。各实验组与对照组比较,差异均有统计学意义(P<0.01)。 Western blot法结果显示随着药物浓度的增加,抗凋亡蛋白Bcl-2表达下调、促凋亡蛋白Bax表达明显上调,各实验组与对照组相比,差异有统计学意义( P <0.01)。结论硫利达嗪对乳腺癌细胞MDA-MB-231、MCF-7有显著的增殖抑制作用且可显著诱导肿瘤细胞发生G0/G1期阻滞及凋亡,伴随Caspase-3活性的上调,其毒性机制可能与肿瘤细胞内抗凋亡蛋白 Bcl-2下调、Bax上调有关。
目的觀察硫利達嗪對人乳腺癌細胞MDA-MB-231和MCF-7的凋亡作用,併探討其機製。方法採用MTT法測定硫利達嗪對細胞的抑製作用,計算半數抑製濃度( IC50);流式細胞術檢測硫利達嗪對細胞週期分佈和凋亡的影響;比色法測定藥物對細胞Caspase-3活性的影響;West-ern blot法檢測凋亡調節蛋白Bcl-2、Bax錶達的變化。結果<br> 硫利達嗪作用24 h後, MDA-MB-231、MCF-7細胞增殖明顯呈劑量依賴性抑製,其IC50為18、22μmol/L。流式細胞術結果顯示,隨著加入硫利達嗪濃度的提高, MDA-MB-231、MCF-7細胞均髮生不同程度的G0/G1期阻滯、細胞凋亡程度增加及伴隨胞內Caspase-3活性增加。各實驗組與對照組比較,差異均有統計學意義(P<0.01)。 Western blot法結果顯示隨著藥物濃度的增加,抗凋亡蛋白Bcl-2錶達下調、促凋亡蛋白Bax錶達明顯上調,各實驗組與對照組相比,差異有統計學意義( P <0.01)。結論硫利達嗪對乳腺癌細胞MDA-MB-231、MCF-7有顯著的增殖抑製作用且可顯著誘導腫瘤細胞髮生G0/G1期阻滯及凋亡,伴隨Caspase-3活性的上調,其毒性機製可能與腫瘤細胞內抗凋亡蛋白 Bcl-2下調、Bax上調有關。
목적관찰류리체진대인유선암세포MDA-MB-231화MCF-7적조망작용,병탐토기궤제。방법채용MTT법측정류리체진대세포적억제작용,계산반수억제농도( IC50);류식세포술검측류리체진대세포주기분포화조망적영향;비색법측정약물대세포Caspase-3활성적영향;West-ern blot법검측조망조절단백Bcl-2、Bax표체적변화。결과<br> 류리체진작용24 h후, MDA-MB-231、MCF-7세포증식명현정제량의뢰성억제,기IC50위18、22μmol/L。류식세포술결과현시,수착가입류리체진농도적제고, MDA-MB-231、MCF-7세포균발생불동정도적G0/G1기조체、세포조망정도증가급반수포내Caspase-3활성증가。각실험조여대조조비교,차이균유통계학의의(P<0.01)。 Western blot법결과현시수착약물농도적증가,항조망단백Bcl-2표체하조、촉조망단백Bax표체명현상조,각실험조여대조조상비,차이유통계학의의( P <0.01)。결론류리체진대유선암세포MDA-MB-231、MCF-7유현저적증식억제작용차가현저유도종류세포발생G0/G1기조체급조망,반수Caspase-3활성적상조,기독성궤제가능여종류세포내항조망단백 Bcl-2하조、Bax상조유관。
Objectives To investigate the anti-proliferative and apoptosis-inducing effects and the possible molecular mechanisms of thioridazine on breast cancer cell lines MDA-MB-231 and MCF-7. Methods The anti-proliferative effects of thioridazine on MDA-MB-231 and MCF-7 cells were measured with MTT and the values of IC50 were calcu-lated. Flow cytometry was used to measure the cell cycle arresting and apoptosis . Caspase -3 activity assay kit was <br> performed to detect Caspase-3 activity levels. The expression changes of the Bcl-2 and Bax were detected by western blot. Results After treated with thioridazine for 24 h, MDA-MB-231 and MCF-7 cells were significantly inhibited by the drug extracts. The values of IC50 were respectively 18μmol/L and 22μmol/L. Flow cytometry showed cells’ G0/G1 phase arrest along with an increase of apoptosis and intracellular Caspase-3 activity with the increase of thio-ridazine concentration. Western blot showed concentration-dependant decrease in Bcl-2 and increase in Bax proteins. Each experimental group compared with the control group, the differences were statistically significant (P<0. 01). Conclusion Thioridazine has obvious cytotoxic effect on breast cancer cells MDA-MB-231 and MCF-7. It obviously induces breast cancer cells G0/G1 phase arresting and apoptosis, accompanied by up-regulation of Caspase-3 activity. The mechanism may be related to the down-regulation of Bcl-2 and up-regulation of Bax.